The landscape of dementia prognosis has evolved dramatically with the appearance of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based checks that could detect Alzheimer's pathology a long time before signs or symptoms emerge. Though these technological improvements signify extraordinary progress in understanding neurodegenerative disorders... https://kingr442rdo4.wikicorrespondence.com/user